Cargando…
Computational Approaches to Discover Novel Natural Compounds for SARS‐CoV‐2 Therapeutics
Scientists all over the world are facing a challenging task of finding effective therapeutics for the coronavirus disease (COVID‐19). One of the fastest ways of finding putative drug candidates is the use of computational drug discovery approaches. The purpose of the current study is to retrieve nat...
Autores principales: | Rampogu, Shailima, Lee, Gihwan, Kulkarni, Apoorva M., Kim, Donghwan, Yoon, Sanghwa, Kim, Myeong Ok, Lee, Keun Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133350/ https://www.ncbi.nlm.nih.gov/pubmed/34010501 http://dx.doi.org/10.1002/open.202000332 |
Ejemplares similares
-
Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2
por: Rampogu, Shailima, et al.
Publicado: (2022) -
Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape
por: Rampogu, Shailima, et al.
Publicado: (2021) -
In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics
por: Rana, Rabia Mukhtar, et al.
Publicado: (2020) -
Computer-Aided Drug Discovery Identifies Alkaloid Inhibitors of Parkinson's Disease Associated Protein, Prolyl Oligopeptidase
por: Kulkarni, Apoorva M., et al.
Publicado: (2021) -
Explicit molecular dynamics simulation studies to discover novel natural compound analogues as Mycobacterium tuberculosis inhibitors
por: Rampogu, Shailima, et al.
Publicado: (2023)